 
            Xavier Matias-Guiu Guia
Degree: PhD
                973 705 340                
                fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
            
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
- 
                        Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patientsJournal Of Medical Genetics 52 647-656. . 
- 
                        McCluggage WG; Judge MJ; Clarke BA; Davidson B; Gilks CB; Hollema H; Ledermann JA; Matias-Guiu X; Mikami Y; Stewart CJ; Vang R; Hirschowitz L Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Modern Pathology 28 1101-1122. . 
- 
                        Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusionsRESPIROLOGY 20 831-833. . 
- 
                        Mancikova V; Castelblanco E; Pineiro-Yanez E; Perales-Paton J; de Cubas AA; Inglada-Perez L; Matias-Guiu X; Capel I; Bella M; Lerma E; Riesco-Eizaguirre G; Santisteban P; Maravall F; Mauricio D; Al-Shahrour F; Robledo M MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumorsModern Pathology 28 748-757. . 
- 
                        Papathomas TG; Oudijk L; Persu A; Gill AJ; van Nederveen F; Tischler AS; Tissier F; Volante M; Matias-Guiu X; Smid M; Favier J; Rapizzi E; Libe R; Currás-Freixes M; Aydin S; Huynh T; Lichtenauer U; van Berkel A; Canu L; Domingues R; Clifton-Bligh RJ; Bialas M; Vikkula M; Baretton G; Papotti M; Nesi G; Badoual C; Pacak K; Eisenhofer G; Timmers HJ; Beuschlein F; Bertherat J; Mannelli M; Robledo M; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger RR SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Modern Pathology 28 807-821. . 
- 
                        Pedrola, N.; Devis, L.; Llauradó, M.; Campoy, I.; Martinez-Garcia, E.; Garcia, M.; Muinelo-Romay, L.; Alonso-Alconada, L.; Abal, M.; Alameda, F.; Mancebo, G.; Carreras, R.; CastellvÃ, J.; Cabrera, S.; Gil-Moreno, A.; Matias-Guiu, X.; Iovanna, J.L.; Colas, E.; Reventós, J.; Ruiz, A. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasionCLINICAL & EXPERIMENTAL METASTASIS 32 467-478. . 
- 
                        Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a modelMethods 77-78 31-40. . 
- 
                        Alonso-Alconada, L.; Santacana, M.; Garcia-Sanz, P.; Muinelo-Romay, L.; Colas, E.; Mirantes, C.; Monge, M.; Cueva, J.; Oliva, E.; Soslow, R.A.; Lopez, M.A.; Palacios, J.; Prat, J.; Valls, J.; Krakstad, C.; Salvesen, H.; Gil-Moreno, A.; Lopez-Lopez, R.; Dolcet, X.; Moreno-Bueno, G.; Reventos, J.; Matias-Guiu, X.; Abal, M. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerINTERNATIONAL JOURNAL OF CANCER 136 1863-1873. . 
- 
                        Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomasVIRCHOWS ARCHIV 466 415-422. . 
- 
                        Chacon, A; Vilar, A; Arroyo, D; Sarro, F; Craver, L; Ros, S; Lopez, C; Castillo, A; Matias-Guiu, X; Fernandez-Giraldez, E Acute kidney failure secondary to very severe hypercalcaemia from primary hyperparathyroidismNefrologia 35 224-226. . 
- 
                        Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistryHUMAN PATHOLOGY 45 2394-2403. . 
- 
                        Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomasCARCINOGENESIS 35 2679-2686. . 
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU